AI
Tuesday, November 06, 2018 7:27:32 AM
TNXP - .655 Pre-market now at .745/.75
*Tonix Pharmaceuticals : Retrospective Analysis Revealed Clinically Meaningful Response to Tonmya in Female PTSD Participants Overall and for Non-Combat-Related Traumas Experienced Within Nine Years Prior to Screening >TNXP
*Tonix Pharmaceuticals : Retrospective Analysis Revealed Clinically Meaningful Response to Tonmya in Female PTSD Participants Overall and for Non-Combat-Related Traumas Experienced Within Nine Years Prior to Screening >TNXP
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
